Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Jun 26, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $701.88 thousand as of June 26, 2026. Its market cap has decreased by -68.60% in one year.
Market Cap
701.88K
Enterprise Value
31.59M
Revenue
12.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 701.88K, a decrease of -99.80%. That is a compound annual growth rate of -59.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 701.88K | -15.46% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearside Biomedical | 1.02M |
| Avenue Therapeutics | 922.59K |
| Agentix | 845.41K |
| Burzynski Research Institute | 788.69K |
| SQZ Biotechnologies Company | 707.79K |
| Halberd | 672.57K |
| Protagenic Therapeutics | 651.49K |
| Windtree Therapeutics | 629.83K |